NEW YORK (GenomeWeb News) – UCB today announced a two-year partnership with Imperial College London to identify master genetic regulators of brain networks that underlie epileptic activity.

The collaboration, UCB said, may result in the discovery of new drug targets and is the first time that cutting edge technologies, such as RNA sequencing and genome-wide approaches, will be applied to translational epilepsy research.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.